Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Inorganic polyphosphate: essential for growth and survival.

Rao NN, Gómez-García MR, Kornberg A.

Annu Rev Biochem. 2009;78:605-47. doi: 10.1146/annurev.biochem.77.083007.093039. Review.

PMID:
19344251
2.

Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI.

Tucker EI, Marzec UM, White TC, Hurst S, Rugonyi S, McCarty OJ, Gailani D, Gruber A, Hanson SR.

Blood. 2009 Jan 22;113(4):936-44. doi: 10.1182/blood-2008-06-163675. Epub 2008 Oct 22.

3.

Clinical practice. Hereditary angioedema.

Zuraw BL.

N Engl J Med. 2008 Sep 4;359(10):1027-36. doi: 10.1056/NEJMcp0803977. Review. No abstract available.

PMID:
18768946
4.

Evolution of the contact phase of vertebrate blood coagulation.

Ponczek MB, Gailani D, Doolittle RF.

J Thromb Haemost. 2008 Nov;6(11):1876-83. doi: 10.1111/j.1538-7836.2008.03143.x. Epub 2008 Aug 28. Erratum in: J Thromb Haemost. 2008 Dec;6(12):2228.

5.

Mechanisms of thrombus formation.

Furie B, Furie BC.

N Engl J Med. 2008 Aug 28;359(9):938-49. doi: 10.1056/NEJMra0801082. Review. No abstract available.

PMID:
18753650
6.

The elusive physiologic role of Factor XII.

Schmaier AH.

J Clin Invest. 2008 Sep;118(9):3006-9. doi: 10.1172/JCI36617. Review.

7.

Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.

Maas C, Govers-Riemslag JW, Bouma B, Schiks B, Hazenberg BP, Lokhorst HM, Hammarström P, ten Cate H, de Groot PG, Bouma BN, Gebbink MF.

J Clin Invest. 2008 Sep;118(9):3208-18. doi: 10.1172/JCI35424.

8.

Novel roles for factor XII-driven plasma contact activation system.

Müller F, Renné T.

Curr Opin Hematol. 2008 Sep;15(5):516-21. doi: 10.1097/MOH.0b013e328309ec85. Review.

PMID:
18695377
9.

Polyphosphate as a general procoagulant agent.

Smith SA, Morrissey JH.

J Thromb Haemost. 2008 Oct;6(10):1750-6. doi: 10.1111/j.1538-7836.2008.03104.x. Epub 2008 Jul 28.

10.

Polyphosphate enhances fibrin clot structure.

Smith SA, Morrissey JH.

Blood. 2008 Oct 1;112(7):2810-6. doi: 10.1182/blood-2008-03-145755. Epub 2008 Jun 10.

11.

The vessel wall and its interactions.

Wagner DD, Frenette PS.

Blood. 2008 Jun 1;111(11):5271-81. doi: 10.1182/blood-2008-01-078204. Review.

12.

Triggers, targets and treatments for thrombosis.

Mackman N.

Nature. 2008 Feb 21;451(7181):914-8. doi: 10.1038/nature06797. Review.

13.

Reduced incidence of ischemic stroke in patients with severe factor XI deficiency.

Salomon O, Steinberg DM, Koren-Morag N, Tanne D, Seligsohn U.

Blood. 2008 Apr 15;111(8):4113-7. doi: 10.1182/blood-2007-10-120139. Epub 2008 Feb 11.

14.

Intrinsic pathway of coagulation and arterial thrombosis.

Gailani D, Renné T.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2507-13. Epub 2007 Oct 4. Review.

15.
16.

Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation.

Kannemeier C, Shibamiya A, Nakazawa F, Trusheim H, Ruppert C, Markart P, Song Y, Tzima E, Kennerknecht E, Niepmann M, von Bruehl ML, Sedding D, Massberg S, Günther A, Engelmann B, Preissner KT.

Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6388-93. Epub 2007 Apr 3.

17.

Evidence of a U-shaped association between factor XII activity and overall survival.

Endler G, Marsik C, Jilma B, Schickbauer T, Quehenberger P, Mannhalter C.

J Thromb Haemost. 2007 Jun;5(6):1143-8.

18.

The intrinsic pathway of coagulation: a target for treating thromboembolic disease?

Gailani D, Renné T.

J Thromb Haemost. 2007 Jun;5(6):1106-12. Epub 2007 Feb 14. Review.

19.

Platelets as immune cells: bridging inflammation and cardiovascular disease.

von Hundelshausen P, Weber C.

Circ Res. 2007 Jan 5;100(1):27-40. Review.

20.

Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice.

Wang X, Smith PL, Hsu MY, Gailani D, Schumacher WA, Ogletree ML, Seiffert DA.

J Thromb Haemost. 2006 Sep;4(9):1982-8.

Supplemental Content

Support Center